Shanghai Journal of Acupuncture and Moxibustion
Therapeutic observation of point application plus Tadalafil in treating erectile dysfunction complicated with depression
LIANG Yuru, OU Yangfan, XU Pan, ZHANG Hong, HUANG Wenbin, XIE Zuogang. Wenzhou Hospital of Integrated Chinese and Western Medicine, Wenzhou 325000, China
[Abstract] Objective To observe the clinical efficacy of point application plus Tadalafil in treating erectile dysfunction complicated with depression. Method A total of 102 patients with erectile dysfunction complicated with depression were randomized into a treatment group of 52 cases and a control group of 50 cases. The treatment group was given point application and oral administration of Tadalafil, and the control group only took Tadalafil. The following outcome measures were observed before and after the treatment in both groups: the international index of erectile function-5 (IIEF-5), Rigiscan AVSS parameters (total tumescence time, basal rigidity ≥60% tumescence time, and tip rigidity ≥60% tumescence time), Hamilton depression scale (HAMD) score, and 36-item short-form healthy survey (SF-36) score. The clinical efficacy was also compared between the two groups. Result The total effective rate was 86.5% in the treatment group, significantly higher than 74.0% in the control group ( P< 0.05). After the treatment, both groups showed notable increases in the IIFE-5 score and Rigiscan AVSS readings ( P< 0.05). The HAMD score dropped significantly, and the SF-36 score increased significantly in the treatment group ( P< 0.05); only the SF-36 score increased in the control group after the intervention ( P< 0.05). After the treatment, the treatment group significantly surpassed the control group in comparing the IIFE-5 score, Rigiscan AVSS readings, and SF-36 score ( P< 0.05). Conclusion Point application plus Tadalafil is an effective approach for erectile dysfunction complicated基金项目:温州市中西医结合学会临床科研基金项目(2021011);浙江省名老中医专家传承工作室建设项目(GZS2020042)作者简介:梁玉如(1992—),女,护师通信作者:欧洋帆(1987—),男,主治医师,Email:ouyf8787@163.com